Novo Nordisk A/S
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]
Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise. The company last week said it would buy […]
Read More
Stocks making the biggest premarket moves: Electronic Arts, Novo Nordisk, Lam Research, Oracle & more
Check out the companies making headlines before the bell: Electronic Arts — Shares rose 5% shortly after a consortium of investors led by Jared Kushner announced it had struck a $55 billion deal to acquire the videogame maker and take it private, confirming earlier reports. Cannabis stocks — The group surged after President Donald Trump […]
Read More
Stocks making the biggest moves midday: Boeing, Paccar, Intel, Mirion Tech and more
Check out the companies making the biggest moves midday: Paccar — The maker of Peterbilt trucks jumped 5% after President Donald Trump slapped a 25% tariff on imported heavy trucks starting Oct. 1. Boeing – The aircraft maker rallied more than 4% after Turkish Airlines ordered 75 Boeing 787 aircraft and said it completed negotiations […]
Read More
Anthropic to triple international workforce in global AI push
Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Anthropic is stepping up its global enterprise ambitions. The $183 billion artificial intelligence startup has grown its business customer base from under 1,000 to more than 300,000 in just two years, as demand for Claude’s models accelerates across industries and regions. On Friday, the company […]
Read More
Stocks making the biggest premarket moves: Paccar, Intel, RH, Riot Platforms and more
Check out the companies making the biggest moves in premarket trading: Paccar — The maker of Peterbilt trucks jumped 7% after President Donald Trump said slapped a 25% tariff on imported heavy trucks starting Oct. 1. Intel — The chip company added 4.4%. The Wall Street Journal reported Intel has approached Apple , Taiwan Semiconductor […]
Read More
Why Trump’s 100% drug tariffs could hit Asia and Europe very differently
Global pharmaceutical stocks sold off on Friday, as markets reacted to news of 100% tariffs on branded and patented drugs imported into the United States, but significant moves lower haven’t been across the board. While Asia Pacific-listed shares in the sector saw notable falls — with some stocks tumbling more than 5% — the reaction […]
Read More
European pharma stocks fall after Trump slaps 100% tariffs on medicine imports
Stocks listed in Europe were broadly higher on Friday, as investors assessed the latest trade policy announcements out of the White House. The pan-European Stoxx 600 index was up by 0.2% by around 10:00 a.m. London time (5 a.m. ET), with most sectors in positive territory. The Stoxx Europe 600 Healthcare index saw rocky trade […]
Read More
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to […]
Read More
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of so-called small molecule drugs, including its closely watched experimental obesity pill. It is the second in […]
Read More